GLP / cGMP Contract Laboratory Services

Article

Visit Intertek during CPhI Booth 3J90. Our innovative pharmaceutical services can expedite product development and support manufacture. Our global network of industry experts and GLP/GMP laboratories are ready to help you.

 


Visit Intertek during CPhIBooth 3J90  

 

With Intertek as your partner, you can trust us to provide a single source solution with expertise that fits your unique needs for both pharmaceuticals and biopharmaceuticals. Over the last 20 years our network of Good Laboratory Practice (GLP) and Good Manufacturing Practice (cGMP) laboratories has provided high quality technical services for some of the world's largest and most innovative pharmaceutical companies.

 

GMP and CMC Laboratory Services 
We provide regulatory-driven, phase-appropriate laboratory services in support of CMC programs seeing you through preformulation, formulation and product release.  Our capabilities include method development and validation, analysisstability studiesextractables and leachablescGMP quality control testing and cGMP batch release testing

 

Bioanalysis Services
During preclinical and clinical development, our biomarker and bioanalysis experts design and manage strategic work programs.  Our expertise and industry insight aims to supply the data you need as quickly and efficiently as possible.

 

Regulatory and Toxicology Consulting
From discovery to commercialisation, our pharmaceutical regulatory consultants provide a fast-track and cost-effective approach to allow you to gain market access.

 

Pharmaceutical Auditing.
Through our shared audit programs, delivered by our global network of specialist auditors, you can benefit from rapid implementation, easier access to audit sites and potential cost savings. 

 

Contact Details:

Intertek Pharmaceutical Services

Website: www.intertek.com/pharmaceutical/

E-mail: pharma.services@intertek.com

 

 

Recent Videos
Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development
Christian Dunne, director of Global Corporate Business Development at ChargePoint Technology
Drug Digest: Focusing on Solid Dosage Trends and Demand
Behind the Headlines, episode 7
Related Content